Inclusion Criteria : 
  -  Participants ongoing in an applicable Bayer - sponsored anetumab ravtansine parent study at the time of its planned study closure . 
  -  For on - treatment participants : participant is eligible to receive the next dose of study intervention per the parent study protocol . 
Exclusion Criteria : 
  -  For on - treatment participants : a positive serum pregnancy test . 
  -  For on - treatment participants : use of one or more of the prohibited medications listed in the respective parent study protocol . 
  -  Participants who are receiving standard - of - care agent ( s ) but not anetumab ravtansine in the parent study , and are able to receive standard - of - care agent outside of the clinical study.